BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37283687)

  • 1. Quantitative proteomic profiling of white matter in cases of cerebral amyloid angiopathy reveals upregulation of extracellular matrix proteins and clusterin.
    Manousopoulou A; Yuen HM; Sharp MM; Saito S; Aldea R; Mazer N; Garbis SD; Carare RO
    Free Neuropathol; 2020 Jan; 1():. PubMed ID: 37283687
    [No Abstract]   [Full Text] [Related]  

  • 2. Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy.
    Manousopoulou A; Gatherer M; Smith C; Nicoll JAR; Woelk CH; Johnson M; Kalaria R; Attems J; Garbis SD; Carare RO
    Neuropathol Appl Neurobiol; 2017 Oct; 43(6):492-504. PubMed ID: 27543695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.
    Endo Y; Hasegawa K; Nomura R; Arishima H; Kikuta KI; Yamashita T; Inoue Y; Ueda M; Ando Y; Wilson MR; Hamano T; Nakamoto Y; Naiki H
    Acta Neuropathol Commun; 2019 Jan; 7(1):12. PubMed ID: 30691533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy.
    Owasil R; O'Neill R; Keable A; Nimmo J; MacGregor Sharp M; Kelly L; Saito S; Simpson JE; Weller RO; Smith C; Attems J; Wharton SB; Yuen HM; Carare RO
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates.
    Zellner A; Müller SA; Lindner B; Beaufort N; Rozemuller AJM; Arzberger T; Gassen NC; Lichtenthaler SF; Kuster B; Haffner C; Dichgans M
    Acta Neuropathol Commun; 2022 Jan; 10(1):6. PubMed ID: 35074002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
    Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy.
    Hawkes CA; Jayakody N; Johnston DA; Bechmann I; Carare RO
    Brain Pathol; 2014 Jul; 24(4):396-403. PubMed ID: 24946077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: sporadic cerebral amyloid angiopathy.
    Attems J; Jellinger K; Thal DR; Van Nostrand W
    Neuropathol Appl Neurobiol; 2011 Feb; 37(1):75-93. PubMed ID: 20946241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases.
    Craggs L; Taylor J; Slade JY; Chen A; Hagel C; Kuhlenbaeumer G; Borjesson-Hanson A; Viitanen M; Kalimo H; Deramecourt V; Oakley AE; Kalaria RN
    Neuropathol Appl Neurobiol; 2016 Feb; 42(2):194-209. PubMed ID: 25940137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.
    Roher AE; Kuo YM; Esh C; Knebel C; Weiss N; Kalback W; Luehrs DC; Childress JL; Beach TG; Weller RO; Kokjohn TA
    Mol Med; 2003; 9(3-4):112-22. PubMed ID: 12865947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter changes in dementia: role of impaired drainage of interstitial fluid.
    Weller RO; Hawkes CA; Kalaria RN; Werring DJ; Carare RO
    Brain Pathol; 2015 Jan; 25(1):63-78. PubMed ID: 25521178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.
    Keable A; Fenna K; Yuen HM; Johnston DA; Smyth NR; Smith C; Al-Shahi Salman R; Samarasekera N; Nicoll JA; Attems J; Kalaria RN; Weller RO; Carare RO
    Biochim Biophys Acta; 2016 May; 1862(5):1037-46. PubMed ID: 26327684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy.
    Bonaterra-Pastra A; Benítez S; Pancorbo O; Rodríguez-Luna D; Vert C; Rovira A; Freijo MM; Tur S; Martínez-Zabaleta M; Cardona Portela P; Vera R; Lebrato-Hernández L; Arenillas JF; Pérez-Sánchez S; Domínguez-Mayoral A; Fàbregas JM; Mauri G; Montaner J; Sánchez-Quesada JL; Hernández-Guillamon M
    Front Aging Neurosci; 2023; 15():1134399. PubMed ID: 37113571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy.
    Camacho J; Moliné T; Bonaterra-Pastra A; Ramón Y Cajal S; Martínez-Sáez E; Hernández-Guillamon M
    Front Neurol; 2019; 10():187. PubMed ID: 30918495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy.
    Jo S; Cheong EN; Kim N; Oh JS; Shim WH; Kim HJ; Lee SJ; Lee Y; Oh M; Kim JS; Kim BJ; Roh JH; Kim SJ; Lee JH
    J Alzheimers Dis; 2022; 86(2):667-678. PubMed ID: 35124637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.
    Inoue Y; Ueda M; Tasaki M; Takeshima A; Nagatoshi A; Masuda T; Misumi Y; Kosaka T; Nomura T; Mizukami M; Matsumoto S; Yamashita T; Takahashi H; Kakita A; Ando Y
    Acta Neuropathol; 2017 Oct; 134(4):605-617. PubMed ID: 28478503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
    J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.